Contact
Please use this form to send email to PR contact of this press release:
Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis
TO:
Please use this form to send email to PR contact of this press release:
Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis
TO: